Bio-Techne (NASDAQ:TECH) reported quarterly earnings of $0.52 per share which met the analyst consensus estimate. This is a 1.89 percent decrease over earnings of $0.53 per share from the same period last year. The company reported quarterly sales of $321.191 million which beat the analyst consensus estimate of $314.679 million by 2.07 percent. This is a 1.33 percent increase over sales of $316.964 million the same period last year.